Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2010-12, Vol.16 (12), p.1529-1530
Hauptverfasser:	Bojar, M, Zajac, M, Meluzínova, E, Houžvičková, E, Libertinová, J, Lišková, P, Mat'oška, V, Nyč, O, Mináriková, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Azathioprine - therapeutic use Humans Immunosuppressive Agents - therapeutic use Indexing in process Interferon-beta - immunology Interferon-beta - therapeutic use Methylprednisolone - therapeutic use Multiple Sclerosis, Relapsing-Remitting - blood Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!